ClinicalTrials.Veeva

Menu

Is There an Ideal Dose of Intravenous Fentanyl in the Prehospital Setting

University of Aarhus logo

University of Aarhus

Status

Completed

Conditions

Acute Pain

Treatments

Other: Fentanyl

Study type

Interventional

Funder types

Other

Identifiers

NCT02914678
AU-PHA2V3

Details and patient eligibility

About

In a previous study the investigators evaluated the apparent efficacy and safety of intravenous fentanyl administered by ambulance personnel and found that 58.4% (CI 56.4-60.4) out of 2348 prehospital patients treated with fentanyl still experienced moderate to severe pain [numeric rating scale (NRS, 0-10) > 3] at hospital arrival. The number of patients with possible fentanyl-related side effects was low.

Therefore, the aim of the present study is to explore the efficacy and safety of a liberalized pain treatment protocol for ambulance personnel (a total of 3 μg/kg per transport) compared with existing restrictive protocol (a total of 2 μg/kg per transport). The investigators hypothesize that:

  • A higher proportion of patients will experience sufficient pain relief at hospital admission (NRS < 4) using the liberalized protocol and
  • There will be no differences in the proportion of potential fentanyl related side-effects are observed.

Full description

A prospective cluster-randomized trial observing proportional differences in sufficient pain relief at hospital admission (NRS < 4) and potential fentanyl related side-effects between patients treated by ambulance personnel applying either:

  • a more liberal treatment approach (a total of 3 μg/kg per transport) or
  • existing treatment approach (a total of 2 μg/kg per transport).

The Ambulance stations and their affiliated ambulance personnel are stratified into 5 clusters according to size/average transports per month and randomized to either liberal or existing treatment approach within each cluster. As patients are not randomized on an individual level baseline differences between the two groups and its patients are adjusted statistically with relevant confounders on 3 overall levels:

  1. Patients: Charlson Comorbidity Index Score, main overall diagnose category, inhospital surrogate measures of disease severity (intensive care unit admission and 30-day mortality).
  2. Ambulance personnel: Years of experience and preinterventional cumulative fentanyl administration and
  3. Ambulance stations and geographical factors: prehospital time measures and geographical distance from site of emergency to hospital.

These covariates are obtained from the Danish National Patient Registry, the Danish Civil Registration System and the electronic prehospital patient journal.

Enrollment

7,093 patients

Sex

All

Ages

Under 110 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with acute pain treated with intravenous fentanyl by ambulance personnel

Exclusion criteria

  • Reduced conscious level (GCS < 15) before initiation of fentanyl treatment
  • Reduced respiratory rate (< 10/minute) before initiation of fentanyl treatment
  • Patient weight < 30 kg
  • Known opioid allergy
  • Women in labour
  • Chronic pain conditions

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

7,093 participants in 2 patient groups

Existing treatment
No Intervention group
Description:
Business as usual: Ambulance personnel use existing treatment approach (a total of 2 μg/kg fentanyl per transport)
More liberal treatment
Experimental group
Description:
Ambulance personnel use a more liberal treatment approach (a total of 3 μg/kg fentanyl per transport)
Treatment:
Other: Fentanyl

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems